Merus Nv logo

Merus Nv share price today

(MRUS)

Merus Nv share price is $42.41 & ₹3,611.59 as on 25 Dec 2024, 2.30 'hrs' IST

$42.41

-0.04

(-0.09%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Merus Nv share price in Dollar and Rupees. Guide to invest in Merus Nv from India. Also see the sentimental analysis on Indian investors investing in Merus Nv. Get details on the Indian mutual funds that are investing in Merus Nv. Get Analyst recommendations and forecasts along with all the Merus Nv's financials.

Merus Nv share price movements

  • Today's Low: $41.96
    Today's High: $43.03

    Day's Volatility :2.48%

  • 52 Weeks Low: $27.11
    52 Weeks High: $61.61

    52 Weeks Volatility :56.0%

Merus Nv Returns

PeriodMerus NvSector (Health Care)Index (Russel 2000)
3 Months
-10.63%
-10.0%
0.0%
6 Months
-25.51%
-5.7%
0.0%
1 Year
48.12%
2.8%
0.0%
3 Years
32.78%
-0.4%
-21.1%

Merus Nv Key Statistics

in dollars & INR

Previous Close
$42.45
Open
$42.81
Today's High
$43.0259
Today's Low
$41.96
Market Capitalization
$2.9B
Today's Volume
$1.3M
52 Week High
$61.61
52 Week Low
$27.11
Revenue TTM
$35.9M
EBITDA
$-228.5M
Earnings Per Share (EPS)
$-4.03
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-44.6%

How to invest in Merus Nv from India?

It is very easy for Indian residents to invest directly in Merus Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Merus Nv stock in both Indian Rupees (INR) and US Dollars (USD). Search for Merus Nv or MRUS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Merus Nv or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Merus Nv shares which would translate to 0.020 fractional shares of Merus Nv as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Merus Nv, in just a few clicks!

Returns in Merus Nv for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Merus Nv investment value today

Current value as on today

₹1,50,375

Returns

₹50,375

(+50.38%)

Returns from Merus Nv Stock

₹47,976 (+47.98%)

Dollar Returns

₹2,399 (+2.4%)

Indian investors sentiment towards Merus Nv

93%

Period: Sep 25, 2024 to Dec 24, 2024. Change in 30 Days versus previous period

Search volume for Merus Nv on INDmoney from India has grown in the last 30 days as on Dec 25, 2024. 93% more investors are searching Merus Nv in the last 30 days versus the previous period.

Global Institutional Holdings in Merus Nv

  • FMR Inc

    10.04%

  • RTW INVESTMENTS, LLC

    6.09%

  • Deerfield Management Co

    4.98%

  • COMMODORE CAPITAL LP

    4.89%

  • Wellington Management Company LLP

    4.22%

  • Samlyn Capital, LLC

    3.81%

Analyst Recommendation on Merus Nv

Buy

    95%Buy

    5%Hold

    0%Sell

Based on 20 Wall street analysts offering stock ratings for Merus Nv(by analysts ranked 0 to 5 stars)

Based on 20 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
19
19
18
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Merus Nv

What analysts predicted

Upside of 102.95%

Current:

$42.41

Target:

$86.07

Insights on Merus Nv

  • Price Movement

    In the last 6 months, MRUS stock has moved down by -25.4%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 7.33M → 11.77M (in $), with an average increase of 37.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -34.45M → -99.90M (in $), with an average decrease of 72.4% per quarter

Merus Nv Financials in INR & Dollars

FY18Y/Y Change
Revenue
$36.0M
↑ 141.72%
Net Income
$-27.8M
↓ 68.34%
Net Profit Margin
-77.17%
↑ 512.02%
FY19Y/Y Change
Revenue
$31.1M
↓ 13.46%
Net Income
$-55.2M
↑ 98.66%
Net Profit Margin
-177.15%
↓ 99.98%
FY20Y/Y Change
Revenue
$29.9M
↓ 3.82%
Net Income
$-85.5M
↑ 55.05%
Net Profit Margin
-285.59%
↓ 108.44%
FY21Y/Y Change
Revenue
$49.1M
↑ 64.0%
Net Income
$-66.8M
↓ 21.86%
Net Profit Margin
-136.06%
↑ 149.53%
FY22Y/Y Change
Revenue
$41.6M
↓ 15.32%
Net Income
$-131.2M
↑ 96.35%
Net Profit Margin
-315.48%
↓ 179.42%
FY23Y/Y Change
Revenue
$43.9M
↑ 5.68%
Net Income
$-154.9M
↑ 18.1%
Net Profit Margin
-352.56%
↓ 37.08%
Q2 FY23Q/Q Change
Revenue
$10.5M
↓ 22.39%
Net Income
$-32.0M
↓ 19.4%
Net Profit Margin
-305.78%
↓ 11.38%
Q3 FY23Q/Q Change
Revenue
$11.0M
↑ 5.32%
Net Income
$-23.0M
↓ 28.16%
Net Profit Margin
-208.57%
↑ 97.21%
Q4 FY23Q/Q Change
Revenue
$8.9M
↓ 18.98%
Net Income
$-60.2M
↑ 161.4%
Net Profit Margin
-672.93%
↓ 464.36%
Q1 FY24Q/Q Change
Revenue
$7.9M
↓ 11.75%
Net Income
$-34.5M
↓ 42.72%
Net Profit Margin
-436.76%
↑ 236.17%
Q2 FY24Q/Q Change
Revenue
$7.3M
↓ 7.06%
Net Income
$-50.0M
↑ 45.23%
Net Profit Margin
-682.52%
↓ 245.76%
Q3 FY24Q/Q Change
Revenue
$11.8M
↑ 60.56%
Net Income
$-99.9M
↑ 99.64%
Net Profit Margin
-848.67%
↓ 166.15%
FY18Y/Y Change
Profit
$35.7M
↑ 140.21%
FY19Y/Y Change
Profit
$-18.5M
↓ 151.77%
FY20Y/Y Change
Profit
$-27.4M
↑ 48.02%
FY21Y/Y Change
Profit
$-37.2M
↑ 35.66%
FY22Y/Y Change
Profit
$29.6M
↓ 179.67%
FY23Y/Y Change
Profit
$43.9M
↑ 48.45%
Q2 FY23Q/Q Change
Profit
$-15.5M
↓ 17.09%
Q3 FY23Q/Q Change
Profit
$-23.8M
↑ 53.89%
Q4 FY23Q/Q Change
Profit
$-27.9M
↑ 17.35%
Q1 FY24Q/Q Change
Profit
$7.3M
↓ 126.09%
Q2 FY24Q/Q Change
Profit
$7.3M
↑ 0.69%
Q3 FY24Q/Q Change
Profit
$11.8M
↑ 60.56%
FY18Y/Y Change
Operating Cash Flow
$-46.3M
↑ 3.21%
Investing Cash Flow
$-25.2M
↓ 39.54%
Financing Cash Flow
$59.0M
↓ 73.59%
FY19Y/Y Change
Operating Cash Flow
$-63.0M
↑ 36.09%
Investing Cash Flow
$24.2M
↓ 196.05%
Financing Cash Flow
$74.2M
↑ 25.79%
FY20Y/Y Change
Operating Cash Flow
$-79.9M
↑ 26.73%
Investing Cash Flow
$-1.5M
↓ 106.15%
Financing Cash Flow
$39.5M
↓ 46.76%
FY21Y/Y Change
Operating Cash Flow
$-59.6M
↓ 25.37%
Investing Cash Flow
$-146.6M
↑ 9766.96%
Financing Cash Flow
$282.0M
↑ 613.45%
FY22Y/Y Change
Operating Cash Flow
$-149.9M
↑ 151.39%
Investing Cash Flow
$2.8M
↓ 101.91%
Financing Cash Flow
$58.7M
↓ 79.17%
Q2 FY23Q/Q Change
Operating Cash Flow
$-41.6M
↑ 13.18%
Investing Cash Flow
$-24.5M
↑ 0.0%
Financing Cash Flow
$66.0M
↑ 30299.54%

Merus Nv Technicals Summary

Sell

Neutral

Buy

Merus Nv is currently in a neutral trading position according to technical analysis indicators.

Merus Nv Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Merus Nv
-6.48%
-25.51%
48.12%
32.78%
176.19%
Regeneron Pharmaceuticals, Inc.
-4.59%
-33.11%
-15.82%
12.66%
91.56%
Biontech Se
-6.0%
37.55%
8.38%
-55.46%
248.4%
Alnylam Pharmaceuticals, Inc.
-3.47%
-1.19%
26.71%
50.37%
106.11%
Vertex Pharmaceuticals Incorporated
-12.22%
-14.5%
-0.59%
82.27%
83.4%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Merus Nv
NA
NA
0.0
-3.75
-0.45
-0.22
NA
10.28
Regeneron Pharmaceuticals, Inc.
17.36
17.36
1.04
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.04
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Merus Nv
Buy
$2.9B
176.19%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.1B
91.56%
17.36
33.61%
Biontech Se
Buy
$27.1B
248.4%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.7B
106.11%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.3B
83.4%
32.84
-4.51%

Merus Nv Dividend announcements

  • Merus Nv Earnings

    Merus Nv’s price-to-earnings ratio stands at None

    Read More

About Merus Nv

merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. our most advanced development programs use the biclonics® format. biclonics® are capable of simultaneously attacking tumors in multiple ways. for example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.
Organization
Merus Nv
Employees
172
CEO
Dr. Sven Ante Lundberg M.D.
Industry
Health Technology

Management People of Merus Nv

NameTitle
Dr. Sven Ante Lundberg M.D.
CEO, President & Executive Director
Mr. Gregory D. Perry
Chief Financial Officer
Mr. Peter B. Silverman J.D.
EVP, Company Secretary, COO, General Counsel, Chief Intellectual Property Officer & Head of US Legal
Dr. Hennie Hoogenboom
Co-Founder and Scientific Advisor
Harry Shuman
Chief Accounting Officer
Mr. Cornelis Adriaan de Kruif Ph.D.
CTO & Executive VP
Dr. Cecilia Anna Wilhelmina Geuijen Ph.D.
Chief Scientific Officer & Senior VP
Ms. Kathleen Farren
IR & Corporate Communications Officer
Ms. Audrey Bergan
Chief People Officer
Ms. Shannon Campbell
Executive VP & Chief Commercial Officer

Important FAQs about investing in Merus Nv from India :

What is Merus Nv share price today?

Merus Nv share price today stands at $42.41, Open: $42.81 ; Previous Close: $42.45 ; High: $43.03 ; Low: $41.96 ; 52 Week High: $61.61 ; 52 Week Low: $27.11. The stock opens at $42.81, after a previous close of $42.45. The stock reached a daily high of $43.03 and a low of $41.96, with a 52-week high of $61.61 and a 52-week low of $27.11.

Can Indians buy Merus Nv shares?

Yes, Indians can invest in the Merus Nv (MRUS) from India.

With INDmoney, you can buy Merus Nv at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Merus Nv at zero transaction cost.

How can I buy Merus Nv shares from India?

It is very easy to buy Merus Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Merus Nv be purchased?

Yes, you can buy fractional shares of Merus Nv with INDmoney app.

What are the documents required to start investing in Merus Nv stocks?

To start investing in Merus Nv, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Merus Nv

Today’s highest price of Merus Nv (MRUS) is $43.03.

Today’s lowest price of Merus Nv (MRUS) is $41.96.

What is today's market capitalisation of Merus Nv

Today's market capitalisation of Merus Nv MRUS is 2.9B

What is the 52 Week High and Low Range of Merus Nv

  • 52 Week High

    $61.61

  • 52 Week Low

    $27.11

What are the historical returns of Merus Nv?

  • 1 Month Returns

    -6.48%

  • 3 Months Returns

    -25.51%

  • 1 Year Returns

    48.12%

  • 5 Years Returns

    176.19%

Who is the Chief Executive Officer (CEO) of Merus Nv

Dr. Sven Ante Lundberg M.D. is the current Chief Executive Officer (CEO) of Merus Nv.